Dorman Products has snapped sharply higher after its Q2 print, reversing the pre-earnings slide and leaving the bulls who faded that weakness looking well-positioned — the question now is whether the move has reset the setup entirely.
The earnings reaction was the dominant event of the week. DORM jumped roughly 11% on August 3 following the Q2 release, then extended another 15.8% on August 4 to close at $147.80. That puts the stock up 3.2% on the week overall, a striking recovery from the $127.68 close flagged in the prior earnings-preview note, where DORM was sliding into the print. The options market was right: the put/call ratio had dropped to 0.625 ahead of results — near its 52-week low — signalling call buyers were fading the pre-earnings weakness rather than hedging against it. That bet paid out cleanly.
Short interest has begun to ease, though it remains meaningful. At 5.74% of free float, shorts trimmed about 2.9% of their exposure over the past week. The month-on-month change shows a similar direction — down roughly 3.8% — suggesting the post-earnings move is prompting some cover rather than fresh conviction either way. Borrow conditions remain relaxed: availability is ample at 332%, meaning there are roughly three shares available to borrow for every two already lent out, and the cost to borrow at 0.84% — while up sharply from 0.43% a week ago and nearly double the month-ago level — is still low in absolute terms. The cost-to-borrow jump is worth watching; the 58% weekly increase is the largest in the 30-day window, suggesting some incremental demand for shorts even as positioning overall eases. Overall, the lending market is far from stressed.
The Street moved quickly after the print. Wells Fargo raised its target to $160 from $155 this morning — the firm's second consecutive lift, having moved to $155 from $140 just two weeks ago on July 21 — while maintaining its Overweight rating. The stock at $147.80 now trades roughly 7% below that revised target, meaning the Street is constructive but not dramatically bullish relative to where the price has already moved. A forward earnings yield close to 6.7% and a PE near 14.9x — which has compressed about 0.7x over the past 30 days as the multiple eased into the run-up — places valuation in mid-range territory for an automotive aftermarket supplier. The 12-month forward EPS growth score ranks in the 96th percentile of the ORTEX universe, a standout that supports the premium over names like SMP, which gained 6% on the day but is up only 2% on the week versus DORM's 3.2%.
The institutional ownership picture adds a layer of stability. BlackRock holds 13.4% of shares, and Reinhart Partners and Channing Capital both appear as new or materially increased holders in the most recent quarter-end data, adding roughly 684,000 and 665,000 shares respectively. Insider activity remains light — recent trades are small, routine sells from directors and the Chief Accounting Officer at prices well below today's close, all carrying minimum significance scores.
What to watch next: the next formal earnings event is flagged for today (August 5), which may indicate a follow-on call or guidance update — how management frames tariff exposure and margin trajectory from here will be the focal point for whether the post-print momentum holds.
See the live data behind this article on ORTEX.
Open DORM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
